Table 2.
Summary of the Variable Survival Data of the Studies.
| Study | Recurrence-free survival (months) | Progression-free survival (months) | Event-free survival (months) | Disease-free survival (months) |
|---|---|---|---|---|
| Xu et al27 (CN) | 4.0 | – | – | – |
| Fu et al28 (CN) | 17.0 | – | – | – |
| Kim et al29 (KR) | – | 32.2 | – | – |
| Haidu et al31 (AT) | – | – | – | 24.3b |
| Zhang et al32 (CN) | – | – | – | 6.8 |
| Kim et al33 (KR) | – | 39.8a | 6.1 | – |
| Giorgio et al34 (IT) | – | 14.0c | – | – |
| Fu et al35 (CN) | 21.0 | – | 13.0 | – |
| Butros et al36 (USA) | – | 36.3 | 21.8 | – |
AT: Austria; CN: China; IT: Italy; KR: Korea; USA: United States of America.
a
Mean value calculation: values are medians unless otherwise stated.
b
Result from the original study, not the updated data set.
c
Data not provided ad numerum in the study but calculated using available data.